{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:13:24Z","timestamp":1790162004549,"version":"4.1.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185332","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T13:27:20Z","timestamp":1518614840000},"page":"e0185332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017\u20132035: Example from Australia"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-1449","authenticated-orcid":true,"given":"Michaela T.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate T.","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Bin","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"ref1","unstructured":"National Screening Unit. Updated Guidelines for Cervical Screening in New Zealand. 2016. https:\/\/www.nsu.govt.nz\/health-professionals\/national-cervical-screening-programme\/cervical-screening-guidelines\/updated<\/ext-link>. Cited 14 September 2017."},{"key":"ref2","unstructured":"Australian Government Department of Health. Overview of the Renewal. 2017. http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/overview-of-the-renewal<\/ext-link>. Cited 14 September 2017."},{"key":"ref3","unstructured":"Ministero della Salute. Piano Nazionale di Prevenzione 2014\u20132018. 2014. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2285_allegato.pdf<\/ext-link>. Cited 14 September 2017"},{"key":"ref4","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Population screening will change (in Dutch). 2014."},{"key":"ref5","first-page":"565","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"M Drolet","year":"2015","journal-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis"},{"key":"ref6","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2011\u20132012. Cancer series no.82. Cat. no. CAN 79. 2014."},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience","author":"SM Garland","year":"2016"},{"key":"ref8","unstructured":"Department of Health and Ageing. Immunise Australia Program\u2014Human Papillomavirus (HPV). 2013."},{"key":"ref9","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"SM Garland","year":"2009"},{"issue":"Suppl 3","key":"ref10","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"CJN Lacey","year":"2006"},{"key":"ref11","first-page":"1576","article-title":"Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination","volume":"141","author":"JML Brotherton","year":"2017"},{"key":"ref12","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication","volume":"128","author":"N Li","year":"2011"},{"key":"ref13","unstructured":"Australian Government Department of Health and Ageing. Human Papillomavirus (HPV). 2011"},{"key":"ref14","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","volume":"32","author":"JML Brotherton","year":"2014"},{"key":"ref15","unstructured":"National HPV Vaccination Register. Coverage Data. 2017."},{"key":"ref16","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"SN Tabrizi","year":"2014"},{"key":"ref17","article-title":"Fall in genital warts diagnoses in the general and Indigenous Australian population following a national HPV vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"MA Smith","year":"2015"},{"key":"ref18","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"H Ali","year":"2013"},{"key":"ref19","first-page":"68","article-title":"Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study","volume":"17","author":"E Chow","year":"2017"},{"key":"ref20","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"S de Sanjose","year":"2010"},{"key":"ref21","unstructured":"Cancer Council Australia Cervical Cancer Screening Guidelines Working Party. National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding. 2017. http:\/\/wiki.cancer.org.au\/australia\/Guidelines:Cervical_cancer\/Screening<\/ext-link>. Cited 14 September 2017."},{"key":"ref22","unstructured":"Medical Services Advisory Committee. National Cervical Screening Program Renewal: Evidence Review (Assessment Report). MSAC Application No. 1276. 2013."},{"key":"ref23","unstructured":"Jew JB and Simms K, Smith M, Yoon JK, Xu X, Caruana M, et al. National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting (Assessment Report). MSAC Application No. 1276. 2014."},{"key":"ref24","first-page":"96","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"JB Lew","year":"2017"},{"key":"ref25","unstructured":"Australian Government Department of Health. National Cervical Screening Program: Program Overview. 2017. http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/cervical-screening-1<\/ext-link>. Cited 14 September 2017."},{"key":"ref26","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"DM Gertig","year":"2013"},{"key":"ref27","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"JM Brotherton","year":"2013"},{"key":"ref28","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"G Ronco","year":"2014"},{"key":"ref29","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial","volume":"348","author":"KM Elfstrom","year":"2014"},{"key":"ref30","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"DC Rijkaart","year":"2012"},{"key":"ref31","article-title":"Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use","volume":"147","author":"MA Smith","year":"2016"},{"key":"ref32","article-title":"Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand","volume":"11","author":"JB Lew","year":"2016"},{"key":"ref33","article-title":"Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program","volume":"204","author":"MA Smith","year":"2016"},{"key":"ref34","unstructured":"Smith M, Canfell K, Simonella L, Nickson C, Lew JB, Creighton P, et al. Economic Evaluation of the Impact of HPV Vaccination on Cervical Screening in New Zealand. Report prepared for the New Zealand Ministry of Health -National Screening Unit. 2009."},{"key":"ref35","article-title":"Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies","volume":"29","author":"K Canfell","year":"2011"},{"key":"ref36","article-title":"Expenditure and resource utilisation for cervical screening in Australia","volume":"12","author":"JB Lew","year":"2012"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Canfell K, Lew JB, Smith M, and Walker R. Cost-effectiveness modelling beyond MAVARIC study end-points. MAVARIC\u2014a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Health Technology Assessment 2011; Vol.15: No.3 2011.","DOI":"10.3310\/hta15030"},{"key":"ref38","unstructured":"Canfell K, Clements M, and Harris J. Cost-effectiveness of proposed changes to the national cervical screening program. Report to the New Zealand National Screening Unit. 2007. http:\/\/www.moh.govt.nz\/notebook\/nbbooks.nsf\/0\/A6D8659128128396CC257C44000ACA6F\/$file\/LECG.pdf<\/ext-link>. Cited 11 November 2016."},{"key":"ref39","article-title":"The predicted effect of changes in cervical screening practice in the UK: results from a modelling study","volume":"91","author":"K Canfell","year":"2004"},{"key":"ref40","article-title":"Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study","volume":"345","author":"R Legood","year":"2012"},{"key":"ref41","unstructured":"National Health and Medical Research Council. Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities. 2005."},{"key":"ref42","unstructured":"Victorian Cervical Cytology Register. Statistical Report 2013. 2014."},{"key":"ref43","unstructured":"Australian Bureau of Statistics. 3222.0 Population Projections, Australia. 2013."},{"key":"ref44","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2010\u20132011. Cancer series no. 76. Cat. no. CAN 72. 2013."},{"key":"ref45","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2012\u20132013. Cancer series no. 93. Cat. no. CAN 91. 2015."},{"issue":"Suppl 5","key":"ref46","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"M Arbyn","year":"2012"},{"key":"ref47","article-title":"Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study","volume":"335","author":"E Davey","year":"2007"},{"key":"ref48","article-title":"Implementation and evaluation of a new automated interactive image analysis system","volume":"50","author":"N Bolger","year":"2006"},{"key":"ref49","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"M Arbyn","year":"2008"},{"key":"ref50","article-title":"Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years","volume":"10","author":"P Creighton","year":"2010"},{"key":"ref51","unstructured":"Kang YJ. Patterns of care study and development of a mode of treatment, survival and mortality for invasive cervical cancer. PhD Thesis, The University of Sydney. 2012."},{"key":"ref52","first-page":"204","article-title":"Differences in screening history, tumor characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992\u20132001","volume":"139","author":"MA van der Aa","year":"2008"},{"key":"ref53","first-page":"220","article-title":"Screening patterns within organized programs and survival of Italian women with invasive cervical cancer","volume":"57","author":"A Zucchetto","year":"2013"},{"key":"ref54","article-title":"Screening and cervical cancer cure: population based cohort study","volume":"344","author":"B Andrae","year":"2012"},{"key":"ref55","unstructured":"National HPV Vaccination Program Register. HPV Vaccination Coverage Data. 2014."},{"key":"ref56","article-title":"Interim Estimates of Human Papillomavirus Vaccination Coverage in the School-Based Program in Australia","volume":"32","author":"J Brotherton","year":"2008"},{"key":"ref57","article-title":"Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18\u201326 years from the National HPV Vaccination Program Register","volume":"35","author":"J Brotherton","year":"2011"},{"key":"ref58","unstructured":"Australian Bureau of Statistics. 3101.0 Australian Demographic Statistics. 2013."},{"key":"ref59","unstructured":"Lew JB and Simms K, Smith MA, Kang YK, Xu XM, Caruana M, et al. National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting. MSAC application number 1276 assessment report. Report to the Medical Services Advisory Committee (MSAC), Department of Health Australia 2014."},{"key":"ref60","article-title":"Cervical screening rates for women vaccinated against human papillomavirus","volume":"201","author":"AC Budd","year":"2014"},{"key":"ref61","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"T Malagon","year":"2012"},{"key":"ref62","article-title":"Evaluation of Type Replacement Following HPV16\/18 Vaccination: Pooled Analysis of Two Randomized Trials","volume":"109","author":"JE Tota","year":"2017"},{"key":"ref63","unstructured":"Pharmaceutical Benefits Advisory Committee (PBAC). July 2017 PBAC Meeting\u2014Positive Recommendations. 2017."},{"key":"ref64","first-page":"59","article-title":"Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia","volume":"1","author":"J Brotherton","year":"2015"},{"key":"ref65","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"E Crowe","year":"2014"},{"key":"ref66","article-title":"Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial","volume":"12","author":"AR Kreimer","year":"2011"},{"key":"ref67","first-page":"597","article-title":"Association of Varying Number of Doses of Quadrivalent Human Papillomavirus With Incidence of Condyloma","volume":"311","author":"E Herweijer","year":"2014"},{"key":"ref68","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"M Brisson","year":"2016"},{"key":"ref69","unstructured":"Simms K, Laprise JF, Smith MA, Lew JB, Caruana M, Brisson M, et al. The cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine in Australia: A comparative modelled analysis. 2015."},{"key":"ref70","unstructured":"Statens Serum Institute. Human papillomavirus-vaccine (HPV) f\u00e6rdigvaccineret, vaccinationstilslutning (in Dutch). 2016; http:\/\/www.ssi.dk\/Smitteberedskab\/Sygdomsovervaagning\/VaccinationSurveillance.aspx?vaccination=6&xaxis=Cohort&sex=0&landsdel=100&show=Graph&datatype=Vaccination&extendedfilters=True#HeaderText<\/ext-link>. Cited 29 August 2017."},{"key":"ref71","unstructured":"Australian Institute of Health and Welfare. Cervical Screening in Australia 2014\u20132015. Cancer series no. 105. Cat. no. CAN 104. 2017."},{"key":"ref72","unstructured":"ClinicalTrials.gov. Compass\u2014Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia. 2014; 2015."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T20:09:18Z","timestamp":1570738158000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185332"}},"subtitle":[],"editor":[{"given":"Marcia Edilaine Lopes","family":"Consolaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185332","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]}}}